Dual-Drug attack on deadly lung pressure in High-Risk heart patients
NCT ID NCT07245680
Summary
This study compares starting treatment with two oral medications versus one medication for people newly diagnosed with pulmonary arterial hypertension (PAH) who also have at least two other heart-related conditions like high blood pressure or diabetes. It aims to find the safest and most effective treatment approach for this high-risk group, which is often excluded from research. About 186 participants in France will be randomly assigned to receive either the two-drug combination or a single drug plus a placebo for 6 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Bicêtre -Service de pneumologie et soins intensifs respiratoires
Le Kremlin-Bicêtre, 94270, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.